Cargando…
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Randomized controlled trials (RCTs) that assess overall survival are considered the “gold standard” when evaluating the efficacy and safety of a new oncology intervention. However, single-arm trials that use surrogate endpoints (e.g., objective response rate or duration of response) to evaluate clin...
Autores principales: | Yap, Timothy A., Jacobs, Ira, Baumfeld Andre, Elodie, Lee, Lauren J., Beaupre, Darrin, Azoulay, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771908/ https://www.ncbi.nlm.nih.gov/pubmed/35070951 http://dx.doi.org/10.3389/fonc.2021.695936 |
Ejemplares similares
-
Trial designs using real‐world data: The changing landscape of the regulatory approval process
por: Baumfeld Andre, Elodie, et al.
Publicado: (2019) -
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations
por: Barry, Elly, et al.
Publicado: (2021) -
Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
por: Azoulay, Laurent
Publicado: (2022) -
Real-world study of patients with locally advanced HNSCC in the community oncology setting
por: Black, Christopher M., et al.
Publicado: (2023) -
Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)